10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026 Feb 12, 2026 04:05PM
10x Genomics Reports Third Quarter 2025 Financial Results Nov 6, 2025 04:05PM
10x Genomics Reports Second Quarter 2025 Financial Results Aug 7, 2025 04:05PM
10x Genomics Reports First Quarter 2025 Financial Results May 8, 2025 04:05PM
10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis Feb 23, 2025 11:30AM
View Older Stories

Feb 12, 2025 04:05PM 10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025
Jan 13, 2025 08:48AM 10x Genomics (TXG) Announces Preliminary Select Fourth Quarter and Full Year 2024 Results
Jan 12, 2025 12:00PM 10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2024 Results
Oct 31, 2024 08:00AM TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative
Oct 30, 2024 06:20AM Canaccord Genuity Reiterates Buy Rating on 10X Genomics (TXG)
Oct 29, 2024 04:05PM 10x Genomics Reports Third Quarter 2024 Financial Results
Aug 8, 2024 04:04PM 10x Genomics Reports Second Quarter 2024 Financial Results
Apr 30, 2024 04:05PM 10x Genomics Reports First Quarter 2024 Financial Results
Mar 26, 2024 09:03AM 10x Genomics (TXG) Commercially Launches Visium HD Spatial Gene Expression Assay
Mar 26, 2024 09:00AM 10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
Feb 15, 2024 04:05PM 10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
Feb 5, 2024 04:05PM 10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting
Jan 8, 2024 09:02AM 10x Genomics (TXG) Announces Preliminary Fourth Quarter and Full Year 2023 Results
Jan 8, 2024 09:00AM 10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results
Dec 19, 2023 09:00AM Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor Invasiveness
Dec 7, 2023 09:00AM 10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human Brain
Nov 6, 2023 04:07PM OWKIN Integrates 10x Genomics (TXG) Spatial Omics and Single-Cell Technologies to the MOSAIC Study
Nov 6, 2023 04:05PM OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study
Nov 2, 2023 04:05PM 10x Genomics Reports Third Quarter 2023 Financial Results
Sep 5, 2023 09:00AM Study Enabled by 10x Genomics Single Cell and Spatial Technologies Explains Why Immunotherapy is More Effective for Certain Brain Tumors Than Others
Aug 3, 2023 04:05PM 10x Genomics Reports Second Quarter 2023 Financial Results
May 24, 2023 04:05PM 10x Genomics (TXG) Launches Visium CytAssist Gene and Protein Expression Assay
May 24, 2023 04:05PM 10x Genomics Launches Visium CytAssist Gene and Protein Expression Assay
May 3, 2023 04:05PM 10x Genomics Reports First Quarter 2023 Financial Results
Feb 15, 2023 04:05PM 10x Genomics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Outlook for 2023
Feb 6, 2023 09:00AM 10x Genomics Demonstrates Breadth, Scale and Leadership at 2023 AGBT General Meeting
Dec 8, 2022 04:05PM 10x Genomics Commercially Launches Xenium Platform for In Situ Analysis
Nov 2, 2022 04:05PM 10x Genomics Reports Third Quarter 2022 Financial Results
Aug 18, 2022 05:08AM UPDATE: Goldman Sachs Downgrades 10X Genomics (TXG) to Sell
Aug 8, 2022 04:05PM 10x Genomics Reports Second Quarter 2022 Financial Results
Jun 7, 2022 07:00AM 10x Genomics Advances Leadership and Innovation in Single Cell and Spatial Technologies at 2022 AGBT General Meeting
May 4, 2022 04:05PM 10x Genomics Reports First Quarter 2022 Financial Results
Apr 14, 2022 08:55AM 10x Genomics Launches Two New Products to Unlock Wider Range of Samples for Single Cell Analysis on Chromium
Feb 22, 2022 04:15PM 10x Genomics Showcases Robust Innovation Pipeline at Xperience 2022 Event
Feb 16, 2022 04:05PM 10x Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Outlook for 2022
Dec 1, 2021 05:06PM 10x Genomics Recognized on The Scientist's Top 10 Innovations List for Fifth Consecutive Year
Aug 4, 2021 04:05PM 10x Genomics Reports Second Quarter 2021 Financial Results
Aug 4, 2021 04:05PM 10x Genomics Reports Second Quarter 2021 Financial Results
Jun 10, 2021 08:00AM 10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shipping
Jun 10, 2021 08:00AM 10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shipping
May 5, 2021 04:36PM 10x Genomics (TXG) Tops Q1 EPS by 16c, Revenues Beat; Offers FY21 Revenues Mid-Point Guidance Below Consensus
May 5, 2021 04:03PM 10x Genomics Reports First Quarter 2021 Financial Results
May 5, 2021 04:03PM 10x Genomics Reports First Quarter 2021 Financial Results
Feb 24, 2021 04:05PM 10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event
Feb 24, 2021 04:05PM 10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event
Oct 5, 2020 04:17PM 10x Genomics (TXG) Signs Agreement to Acquire ReadCoor; Acquires Sweden’s CartaNA AB
Oct 5, 2020 04:15PM 10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions
Oct 5, 2020 04:15PM 10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions
Sep 15, 2020 08:00AM 10x Genomics First to Market With Product to Simultaneously Capture Epigenome and Transcriptome
Sep 15, 2020 08:00AM 10x Genomics First to Market With Product to Simultaneously Capture Epigenome and Transcriptome
View Older Stories